Two Escherichia coli O-rough:K1:H7 strains producing verotoxin 1 that were isolated from stool samples of two travelers with diarrhea who consulted our clinic after trips to the Indian Subcontinent and Central America were characterized. Both strains were sorbitol negative, the same phenotype presented by E. coli O157:H7, but in contrast they were ␤-glucuronidase positive. Low-frequency restriction analysis of chromosomal DNA and pulsed-field gel electrophoresis and repetitive extragenic palindrome-PCR showed that both strains were epidemiologically related. The illness was self-limited in both cases but involved long-duration, watery diarrhea (10 to 50 days) accompanied by abdominal cramps and flatulence. This serotype should be taken into account as a possible cause of traveler's diarrhea.
Verotoxin (VT)-producing Escherichia coli (VTEC) is an important cause of diarrhea, which can sometimes be complicated by hemorrhagic colitis and hemolytic-uremic syndrome (HUS) (10) . VTEC consists of a number of serotypes, of which O157:H7 is the most commonly recognized as a cause of diarrhea or HUS. Epidemiologic and microbiologic studies have demonstrated that E. coli serotype O157:H7 accounts for 40 to 70% of VTEC infections (13) . However, investigations of the prevalence of VTEC infections in patients with diarrheal illness have more commonly been confined to the recovery of this serotype from stools because of technical limitations in the detection of other serotypes (13) . Despite this, over 100 non-O157:H7 serotypes of VTEC have been isolated from humans, some causing HUS and others causing only diarrhea (13) .
Diarrhea is by far the most frequent health problem of Spanish travelers to developing countries (8) . Enterotoxigenic E. coli is the most important causative agent of traveler's diarrhea; however, many episodes of traveler's diarrhea remain without recognized etiologies (9) . The unrecognized causes may be other enteropathogens, such as VTEC, that are not uniformly tested for. As far as we know, no systematic search for VTEC has been conducted in the different studies of traveler's diarrhea described in the scientific literature.
In this report, we present the characterization of two VTEC strains isolated from stool samples of two travelers with diarrhea who consulted our clinic after trips to developing countries.
MATERIALS AND METHODS

Patient 1.
A 40-year-old man with diarrhea who consulted our clinic had traveled to Venezuela and the Dominican Republic for 1 month. Three days before his return, he developed watery diarrhea (two or three times daily) with mucus. The diarrhea was accompanied by abdominal cramps, nausea, and flatulence. On the third day, he was febrile (38.5°C) and the deposition frequency increased to up to 10 times a day. The fever disappeared 1 day later without treatment, but asthenia developed. Stool specimens were collected for microbiological examination 7 days after disease onset. Hematologic and biochemical blood tests were normal. No treatment was given. The diarrhea stopped 10 days after onset with total recovery. During the trip, he visited rural areas away from the touristic circuits and consumed raw meat, local vegetables, and fruit juice.
Patient 2.
A 32-year-old female with diarrhea who also consulted our clinic had traveled to the Indian Subcontinent. On the seventh day of the trip, she developed watery diarrhea (three times a day) with the presence of mucus. Other symptoms were fever, vomiting, abdominal cramps, flatulence, asthenia, and weight loss (3 kg). She self-prescribed tetracycline (3 days) and loperamide. After disease onset, she had intermittent loose stools with flatulence, asthenia, and belching. One month after disease onset, microbiological stool tests were performed. Hematologic and biochemical blood tests were normal. The illness lasted 50 days and was self-limited. During the trip, she ate in the hotels where she stayed and also in local restaurants, consuming a variety of salads, fruits, meat, cold and warm tea, and local fruit juices.
Microbiological and biochemical tests. Both stool samples were cultured for bacterial enteric pathogens including Salmonella, Shigella, Campylobacter, Aeromonas, Plesiomonas, and Yersinia spp. by standard conventional methods (21) . The stool samples were also cultured on MacConkey agar-sorbitol. The samples were also examined for ova and parasites. Rotavirus was the only virus causing gastroenteritis tested for.
The biochemical characterization of the strains was performed by using the API 20E and API 50CHE systems (bioMerieux, Marcy l'Etoile, France).
Antimicrobial susceptibility. Susceptibility to antimicrobial agents was carried out by using an automated microdilution system (MicroScan Walkaway; Baxter, Co., West Sacramento, Calif.).
Detection of VTs by PCR. Two colonies of sorbitol-negative bacilli were selected for further biochemical and PCR testing. Bacteria were grown on MacConkey agar overnight. Half a colony of each isolate was suspended in 25 l of a reaction mixture containing 20 mM Tris-HCl (pH 8.8), 100 mM KCl, 3.0 mM MgCl, 0.1% gelatin, and 400 M deoxynucleoside triphosphates, and 1 M primer was added, together with 2.5 U of Taq polymerase (GIBCO-BRL). The reaction mixture was overlaid with oil and subjected to 30 cycles of 95°C for 50 s, 55°C for 1.5 min, and 72°C for 2 min. Two sets of primers for VT-1 and two sets of primers for VT-2, obtained from Boehringer, Mannheim, Germany, were used as previously indicated (11, 12, 25) .
The PCR assay was performed in a DNA Thermal Cycler 480 (Perkin-Elmer Cetus, Emeryville, Calif.). A reagent blank which contained all of the components of the reaction mixture except the bacteria was included in every PCR procedure. A clinical strain of E. coli serotype O157:H7 producing both VT-1 and VT-2 was included as a positive control. Amplification products were analyzed by electrophoresis in a 2% agarose gel and detected by staining with ethidium bromide.
REP (repetitive extragenic palindrome)-PCR. The conditions described above were used for REP-PCR. The primers used had the sequences 5ЈIIIICGICGI CATCIGGC3Ј and 5ЈICGICTTATCIGGCCTAC3Ј, and PCR amplification was performed with 30 cycles at 94°C for 1 min, 40°C for 1 min, and 65°C for 8 min, with a single final extension of 65°C for 16 min. Samples (20 l) of each PCR end product were analyzed on 1.5% (wt/vol) agarose gels.
Low-frequency restriction analysis of chromosomal DNA. Genomic DNA was isolated by a slightly modified version of the method of Matushek et al. (20) . In brief, 3 ml of an overnight culture was centrifuged and resuspended in 0.5 ml of 2ϫ lysis buffer (1ϫ lysis buffer contains 6 mM Tris-HCl [pH 7.4], 1 M NaCl, 10 mM EDTA [pH 7.5], 0.5% Brij, 0.2% deoxycholate, and 0.5% sodium lauryl sarcosinate) to which lysozyme (Sigma, St. Louis, Mo.) at 0.5 mg/ml and RNase (Sigma) at 10 g/ml were added. Genomic DNA was prepared in agarose plugs as described previously (18) . It was then incubated with 3 ml of 1ϫ lysis solution at 37°C for 2 h with gentle shaking. After incubation, the lysis solution was replaced with ESP (10 mM Tris-HCl [pH 7.4], 1 mM EDTA), to which proteinase K (Sigma) at a final concentration of 100 g/ml and 1% sodium dodecyl sulfate were added, and the plugs were incubated at 50°C for 1 h. Protein digestion products were removed by washing the plugs thrice with TE buffer (10 mM Tris-HCl [pH 7.4], 0.1 mM EDTA) at 50°C for 5, 30, and 30 min.
A plug slice 4 mm wide was suspended in 500 l of restriction buffer for 1 h at 37°C. After that, the restriction buffer was replaced by 250 l of new restriction buffer and it was incubated overnight with 20 U of XbaI (Promega) by following the manufacturer's recommendations. The DNA fragments generated were separated in a 1% agarose pulsed-field electrophoresis gel (Bio-Rad) that was prepared and run in Tris-borate-EDTA (TBE) buffer on a contour-clamped homogeneous electric field apparatus (CHEF-DR2; Bio-Rad). The conditions for electrophoresis were 200 V for 20 h, with pulse times ranging from 5 to 40 s. Thereafter, the gels were stained with ethidium bromide and photographed.
Determination of serotypes. The strains were kindly serotyped by the Statens Seruminstitut, Copenhagen, Denmark.
RESULTS
In the two cases of traveler's diarrhea described here, no "classical" enteric pathogens (bacteria, parasites, or viruses) were detected. The predominant bacterium isolated in the stools was E. coli. The biochemical characteristics of the E. coli strains (designated 50DV and 118DV) isolated from these patients are shown in Table 1 . The strains were ␤-galactosidase negative, an unusual characteristic, and both were sorbitol negative and ␤-glucuronidase positive. Fermentation of Darabinose was the only biochemical difference found between them; whereas strain 50DV could not ferment D-arabinose, strain 118DV could. To detect possible virulence factors of the E. coli isolates, PCR assays for VT-1 and VT-2, heat-stable and heat-labile toxins, and invasiveness were performed. The PCRs for heat-stable and heat-labile toxins and invasiveness were negative (data not shown), whereas when two sets of primers specific for VT-1 and VT-2 were used, a positive reaction for VT-1 was found. With the VT-1 primers described in reference 11, an amplicon of 894 bp was observed in the control strain and also in both test strains (Fig. 1) , whereas with the specific VT-2 primers described in reference 12, an amplicon of 478 bp was observed only in the control strain. To confirm these results, another set of primers, described in reference 25, was used. An amplicon of 130 bp for VT-1 was observed in the control strain and in both test strains (50DV and 118DV), whereas an amplicon of 346 bp corresponding to VT-2 was observed only in the control strain (Fig. 1) .
Both strains of E. coli were also tested for hemolysin production and the presence of the eaeA gene (data not shown), but no evidence of the presence of these virulence factors was found. The strains were sent to the Statens Seruminstitut for serotyping, and surprisingly, both strains were O-rough:K1:H7. They also verified the production of cytotoxin by a cytotoxin assay using Vero cells.
The antimicrobial susceptibility results for each strain are shown in Table 2 . Strain 50DV was resistant to tetracycline (MIC, Ͼ8 g/ml), whereas strain 118DV was resistant to both tetracycline (MIC, Ͼ8 g/ml) and cotrimoxazole (MIC, Ͼ2 g/ml).
Both patients had watery diarrhea. Fever, abdominal cramps, and nausea were complaints common to both cases. Two follow-up stool specimens were obtained 1 and 2 weeks after the diarrhea stopped, and in neither case was VTEC isolated. The durations of illness were 10 and 50 days, respectively.
To analyze the epidemiological relationship between the strains, REP-PCR and low-frequency restriction analysis of chromosomal DNA were used. The profiles of both strains generated with REP primers were exactly the same and contained seven bands, ranging in size from 0.2 to 2.5 kb (Fig. 2A) . Similar patterns were produced by strains 50DV and 118DV when their DNA were digested with XbaI and the DNA fragments generated were separated by pulsed-field gel electrophoresis. A difference of only one band was seen (Fig. 2B) .
DISCUSSION
Enterotoxigenic E. coli is the major cause of traveler's diarrhea in people from industrialized countries who visit lessdeveloped countries. Other types of enteropathogenic E. coli, such as VTEC, are not frequently implicated as a cause of traveler's diarrhea. Although in the present study, data were not available to determine what percentage of the patients with traveler's diarrhea have VTEC (studies are in progress), we describe the characterization of two strains of E. coli serotype O-rough:K1:H7 producing VT-1 which caused traveler's diarrhea in two patients. Interestingly, both patients, one coming from the Indian Subcontinent and the other from Central America, yielded strains of the same serotype. Despite the different geographical locations, both strains were phenotypically and genetically similar, either by low-frequency restriction analysis of chromosomal DNA and separation by pulsed-field gel electrophoresis or by REP-PCR.
Infection with VTEC may have a range of effects, from mild, watery diarrhea to hemorrhagic colitis and, in some cases, HUS. A 2-year survey of stool cultures in Calgary, Alberta, Canada, found that VTEC (mostly O157:H7) was the single most commonly identified cause of bacterial diarrhea (23) . In a Belgian study (24) , the overall rate of VTEC isolation was about 1% among the 10,241 stool specimens analyzed. In this positive subset, 38% of the isolates were O157:H7 but 62% were non-O157 serotype isolates (comprising 22 different O:H types). In Europe, Australia, and South America, several non-O157 serotypes have been isolated, some causing outbreaks (2, 4, 6, (14) (15) (16) . As far as we know, no E. coli O-rough:K1:H7 strain has been previously described among these isolates.
The illness caused by E. coli O157:H7 is self-limited in most cases, usually lasting approximately 7 days, and the role of antimicrobial therapy is unknown. In fact, several researchers have suggested that antimicrobial therapy may either increase or decrease the risk of HUS. Some studies suggest that antibiotics may increase VT excretion from VTEC strains (28) . Other investigators have reported good results with antibiotic therapy (19) . Probably, as occurs in shigellosis, inappropriate antibiotic therapy may play a role in the development of HUS (3). In our study, patient 2 took doxycycline although the strain was resistant to this antibiotic. Tetracycline alone is no longer useful for the treatment of enteritis because most bacterial isolates from tropical and subtropical countries are resistant as a result of the intensive use of this antibiotic in developing countries (27) . The finding of nonbloody diarrhea with E. coli O-rough:K1:H7 is consistent with the observation of other investigators (1, 16, 23 ) that the diarrhea induced by VTproducing organisms other than E. coli O157:H7 is nonbloody.
The relatively long illnesses of these patients (10 days for patient 1 and 50 days for patient 2) could be unusual and could not be related to any underlying diseases or immunosuppression. Although most diarrheal illnesses caused by E. coli O157:H7 last a mean of 5 to 6 days, a longer duration has been described for VT-producing organisms other than E. coli O157:H7 (1, 23) .
The absence of sorbitol fermentation by E. coli O157:H7 is a characteristic phenotype, and sorbitol-MacConkey agar has been used to detect this serotype (17) and could also be used to detect the strains analyzed in this study since they were sorbitol negative. In addition, this serotype cannot ferment rhamnose, which has also been used as a source of carbon in a selective medium (7) . Biochemical characterization of Orough:K1:H7 strains showed that, in addition to having an atypical ␤-galactosidase-negative phenotype, they were rhamnose positive. E. coli serotype O157:H7 strains have been reported to be uniformly ␤-glucuronidase negative (26) , whereas strains of most other serotypes, including O-rough:K1:H7, are ␤-glucuronidase positive.
Although some VTEC strains cause attaching-and-effacing lesions on enterocytes, similar to those caused by enteropatho- FIG. 1 . Detection of VT-1 and VT-2 by PCR. Lanes: M, DNA molecular weight marker VI from Boehringer; 1 to 4, VT-1 amplified by using the primers described in reference 11; 5 to 8, VT-2 amplified by using the primers described in reference 12; 9 to 12, VT-1 amplified by using the primers described in reference 25; 13 to 16, VT-2 amplified by using the primers described in reference 25. Lanes 1, 5, 9, and 13 contained a clinical strain of E. coli O157:H7; lanes 2, 3, 6, 7, 10, 11, 14, and 15 contained the two O-rough:K1:H7 strains; and lanes 4, 8, 12 , and 16 were PCR blanks. 
a R, resistance; S, susceptibility.
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on July 7, 2017 by guest http://jcm.asm.org/ genic E. coli, their most important characteristic is the ability to produce large amounts of one or both VTs. However, in addition to VT production, some VTEC strains probably possess other properties that may be required for full virulence. Non-O157 VTEC strains have been isolated from individuals without diarrhea (5). However, E. coli O157:H7 strains have also been recovered from asymptomatic persons (10) . It has been shown that E. coli O157:H7 and other VTEC strains produce a hemolysin that may be involved in virulence (5) . The virulence factors related to human VTEC, such as the presence of the eaeA gene or Hly could not be detected in the strains studied, although diarrhea-causing strains of other serotypes have been found that also lack these factors. The K1 antigen is the most common K antigen present in E. coli strains found in the intestinal tracts of healthy people, and it has been considered an important virulence factor related to invasiveness (22) . However, its role in the pathogenicity of the diarrhea caused by these VTEC strains is difficult to ascertain.
In conclusion, this report describes two epidemiologically related VTEC serotype O-rough:H1:K7 strains causing longduration traveler's diarrhea. Although the percentage of patients with traveler's diarrhea caused by VTEC remains to be studied, this serotype has to be taken into account. Furthermore, clinical microbiology laboratory workers must decide whether to screen for VTEC strains in stool samples from patients with traveler's diarrhea.
